Loading…

Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

Saved in:

Bibliographic Details
Published in:	Leukemia 2022-01, Vol.36 (1), p.288-291
Main Authors:	Jelinek, Tomas, Sevcikova, Tereza, Zihala, David, Popkova, Tereza, Kapustova, Veronika, Broskevicova, Lucie, Capkova, Lenka, Rihova, Lucie, Bezdekova, Renata, Sevcikova, Sabina, Zidlik, Vladimir, Havel, Martin, Plonkova, Hana, Jungova, Alexandra, Minarik, Jiri, Stork, Martin, Pour, Ludek, Pavlicek, Petr, Spicka, Ivan, Maisnar, Vladimir, Radocha, Jakub, Simicek, Michal, Hajek, Roman
Format:	Article
Language:	English
Subjects:	13/1 13/31 38/91 45/90 692/308/575 692/700/565/251 Antibodies Antibodies, Monoclonal - therapeutic use Antigens Antineoplastic Agents - therapeutic use Cancer Research Clone Cells - drug effects Clone Cells - pathology Critical Care Medicine Cytotoxicity Flow cytometry Follow-Up Studies Hematology Hospitals Humans Immunotherapy Intensive Internal Medicine Letter Leukemia Medicine Medicine & Public Health Monoclonal antibodies Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - pathology Oncology Plasma Cells - drug effects Plasma Cells - pathology Prognosis Retrospective Studies Survival Rate Targeted cancer therapy
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!